Bionano Genomics Future Growth
Future criteria checks 2/6
Bionano Genomics is forecast to grow earnings and revenue by 57.3% and 24.9% per annum respectively while EPS is expected to grow by 81.2% per annum.
Key information
57.3%
Earnings growth rate
81.2%
EPS growth rate
| Life Sciences earnings growth | 16.7% |
| Revenue growth rate | 24.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Mar 2024 |
Recent future growth updates
Recent updates
Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Earnings Pushing Shares 31% Lower
May 09
Bionano Genomics, Inc. (NASDAQ:BNGO) Analysts Just Trimmed Their Revenue Forecasts By 9.0%
Mar 14Bionano Genomics: Little Clinical Utility And A Whole Lot Of Burn
Oct 18Bionano stock dips amid launch of Bionano Laboratories for optical genome mapping tests
Sep 23Bionano jumps 36% as publication highlights optical genome mapping
Aug 11Bionano stock down ~8% after hours; co reports Q2 revenue beat, wider loss
Aug 04Bionano gets US patent for analysis of nucleic acid fragments for genetic abnormalities
Jun 29I'm More Positive But Selling Puts Instead Of Buying Bionano Genomics
Jun 23Here's Why We're Not Too Worried About Bionano Genomics' (NASDAQ:BNGO) Cash Burn Situation
Apr 11Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 74 | -53 | N/A | N/A | 1 |
| 12/31/2025 | 51 | -69 | N/A | -71 | 4 |
| 12/31/2024 | 39 | -88 | N/A | -84 | 4 |
| 12/31/2023 | 36 | -232 | -127 | -125 | N/A |
| 9/30/2023 | 34 | -227 | -132 | -130 | N/A |
| 6/30/2023 | 32 | -147 | -136 | -133 | N/A |
| 3/31/2023 | 30 | -140 | -127 | -125 | N/A |
| 12/31/2022 | 28 | -133 | -128 | -125 | N/A |
| 9/30/2022 | 26 | -117 | -119 | -116 | N/A |
| 6/30/2022 | 23 | -106 | -109 | -106 | N/A |
| 3/31/2022 | 21 | -92 | -93 | -91 | N/A |
| 12/31/2021 | 18 | -72 | -73 | -72 | N/A |
| 9/30/2021 | 16 | -61 | -59 | -58 | N/A |
| 6/30/2021 | 13 | -51 | -49 | -49 | N/A |
| 3/31/2021 | 11 | -41 | -44 | -44 | N/A |
| 12/31/2020 | 9 | -41 | -38 | -38 | N/A |
| 9/30/2020 | 7 | -37 | -36 | -36 | N/A |
| 6/30/2020 | 8 | -33 | -32 | -32 | N/A |
| 3/31/2020 | 9 | -32 | -31 | -31 | N/A |
| 12/31/2019 | 10 | -30 | -30 | -30 | N/A |
| 9/30/2019 | 11 | -28 | -24 | -24 | N/A |
| 6/30/2019 | 11 | -27 | -23 | -23 | N/A |
| 3/31/2019 | 12 | -23 | -20 | -20 | N/A |
| 12/31/2018 | 12 | -18 | -20 | -20 | N/A |
| 9/30/2018 | 11 | -18 | -19 | -19 | N/A |
| 6/30/2018 | 11 | -18 | -19 | -18 | N/A |
| 3/31/2018 | 10 | -22 | -21 | -20 | N/A |
| 12/31/2017 | 10 | -23 | -22 | -21 | N/A |
| 12/31/2016 | 7 | -19 | N/A | -23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BNGO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BNGO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BNGO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BNGO's revenue (24.9% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: BNGO's revenue (24.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BNGO's Return on Equity is forecast to be high in 3 years time